Drug Chatter -- Tracking biopharma stock chatter

Profile for MediciNova, Inc. (MNOV)

« Back to company index

MNOV Chatter Timeline

Stock Ticker for MNOV

Most Active Tweeters for MNOV

UserTweets
@filingBot 4
@VCapital_invest 3
@jimmiebjorling 3
@lexooj 2
@RoboSchmobo 2

Recent Tweets for MNOV

PaceTrading77 @PaceTrading77
I really recommend everyone check this out for finding good stocks to trade https://t.co/JqXzrBifBf $MNOV $MTBC… https://t.co/4S6PqqHfvk
12:11am
zackcappsocial @zackcappsocial
Positive Results for Multiple Sclerosis Patients https://t.co/1gfmgkgWMd $MNOV @davidbautz #biotech https://t.co/Z4eWhXFFR3
November 18th 2017, 7:11am
IBAB4 @IBAB4
RT @ZacksAwareness: Positive Results for Multiple Sclerosis Patients https://t.co/6vkBG33dTP $MNOV @davidbautz #biotech https://t.co/VXSprD…
November 17th 2017, 9:11pm
ahighelevation @ahighelevation
Positive Results for Multiple Sclerosis Patients https://t.co/G9hdtYKjcI $MNOV @davidbautz #biotech https://t.co/TIiXWWZtVR
November 17th 2017, 8:11pm
ZacksAwareness @ZacksAwareness
Positive Results for Multiple Sclerosis Patients https://t.co/6vkBG33dTP $MNOV @davidbautz #biotech https://t.co/VXSprDKrC3
November 17th 2017, 5:11pm
InstitutionalZC @InstitutionalZC
Positive Results for Multiple Sclerosis Patients https://t.co/4sljnujUTs $MNOV @davidbautz #biotech https://t.co/w6dPLFAZ3h
November 17th 2017, 2:11pm
RoboSchmobo @RoboSchmobo
RT @zackcapp: Positive Results for Multiple Sclerosis Patients https://t.co/K1Vr5CZBrl $MNOV @davidbautz #biotech https://t.co/2JcBN32azk
November 17th 2017, 8:11am
zackcapp @zackcapp
Positive Results for Multiple Sclerosis Patients https://t.co/K1Vr5CZBrl $MNOV @davidbautz #biotech https://t.co/2JcBN32azk
November 17th 2017, 7:11am
PiggyBankPeople @PiggyBankPeople
RT @HowieRegay: Positive Results for Multiple Sclerosis Patients https://t.co/TJdfvN4zLK $MNOV @davidbautz #biotech https://t.co/eOsWSJ2XBe
November 16th 2017, 9:11pm
HowieRegay @HowieRegay
Positive Results for Multiple Sclerosis Patients https://t.co/TJdfvN4zLK $MNOV @davidbautz #biotech https://t.co/eOsWSJ2XBe
November 16th 2017, 9:11pm
RoboSchmobo @RoboSchmobo
RT @PortfolioPenny: Positive Results for Multiple Sclerosis Patients https://t.co/B0Qiv2tfM5 $MNOV @davidbautz #biotech https://t.co/y0OHrf…
November 16th 2017, 5:11pm
PiggyBankPeople @PiggyBankPeople
Positive Results for Multiple Sclerosis Patients https://t.co/PNBDFoeJTo $MNOV @davidbautz #biotech https://t.co/yzBl1FTNge
November 16th 2017, 5:11pm
PortfolioPenny @PortfolioPenny
Positive Results for Multiple Sclerosis Patients https://t.co/B0Qiv2tfM5 $MNOV @davidbautz #biotech https://t.co/y0OHrfiL8w
November 16th 2017, 5:11pm
4thQuarterCap @4thQuarterCap
Trimmed $MNOV +9%. Thanks again @SheffStation for showing us that one a couple months back. ALS data in early December
November 16th 2017, 4:11pm
VCapital_invest @VCapital_invest
Positive Results for Multiple Sclerosis Patients $MNOV @davidbautz #biotech https://t.co/2B3p65ZUBK https://t.co/Rb7lRNCUxq
November 16th 2017, 2:11pm
jimmiebjorling @jimmiebjorling
Positive Results for Multiple Sclerosis Patients $MNOV @davidbautz #biotech https://t.co/sMiLJ57z7r https://t.co/sN7Cp33ICB
November 16th 2017, 2:11pm
lexooj @lexooj
Nearly 3 weeks since $MNOV announced results from the progressive MS trial and still no data on disability. Company… https://t.co/Sqs9jT17nB
November 14th 2017, 10:11am
filingBot @filingBot
@DaveSD80 there is a new form 4 filing for $MNOV https://t.co/dfRUyPkPnF Please RT.
November 13th 2017, 5:11pm
filingBot @filingBot
@DaveSD80 there is a new form 3 filing for $MNOV https://t.co/Gf85FX6em4 What do you think?
November 13th 2017, 5:11pm
4thQuarterCap @4thQuarterCap
Back in $MNOV for ALS data in early December
November 13th 2017, 5:11pm
filingBot @filingBot
@DaveSD80 there is a new form 8-K filing for $MNOV https://t.co/4uW61dpIBZ Spread the word!
November 13th 2017, 7:11am
surveyist @surveyist
RT @AF_biotech: $MNOV PR won't go far as data presentation on Saturday will provide a much needed reality check. I would NOT hold my breath.
November 11th 2017, 1:11am
MaisaCorp @MaisaCorp
$MNOV Plans Trial of MN-166 for Treating Methamphetamine Use Disorder
November 10th 2017, 8:11am
CRWECrownEquity @CRWECrownEquity
$MNOV Makes Strategic Move https://t.co/x0neB1frpA
November 10th 2017, 2:11am
CRWECrownEquity @CRWECrownEquity
$MNOV, US Dept of Veterans Affairs, Oregon Health & Science Univ. to Evaluate MN-166 in Methamphetamine Use Disorder https://t.co/2Tc87wwFJu
November 10th 2017, 2:11am
stockboardinc @stockboardinc
$MNOV MediciNova Appoints Hideki Nagao to its Board of Directors... - https://t.co/kGBWembgze
November 10th 2017, 1:11am
Allstocknews @Allstocknews
$MNOV MediciNova Appoints Hideki Nagao to its Board of Directors From our Stock News Alerts App
November 10th 2017, 1:11am
GNWLive @GNWLive
MediciNova Appoints Hideki Nagao to its Board of Directors $MNOV https://t.co/680v8w2hnt
November 10th 2017, 1:11am
GNWLive @GNWLive
MediciNova Announces Collaboration with the U.S. Department of Veterans Affairs and Oregon Health & Science $MNOV https://t.co/eyaRkPXKep
November 9th 2017, 6:11pm
Kittizens @Kittizens
RT @VCapital_invest: MN-166 Achieves Primary Endpoint in Progressive MS Study $MNOV @davidbautz #biotech https://t.co/cyKJwe8ghh https://t.…
November 7th 2017, 4:11pm
wlstcom @wlstcom
MNOV: Positive Results in Phase 2b Study of MN-166 in Progressive MS #biotech $MNOV https://t.co/S6DviHMrfm https://t.co/k5G20t0A0T
November 7th 2017, 4:11pm
VCapital_invest @VCapital_invest
MN-166 Achieves Primary Endpoint in Progressive MS Study $MNOV @davidbautz #biotech https://t.co/cyKJwe8ghh https://t.co/HU1AtI2Vc9
November 7th 2017, 4:11pm
jimmiebjorling @jimmiebjorling
MN-166 Achieves Primary Endpoint in Progressive MS Study $MNOV @davidbautz #biotech https://t.co/xjaa7abfHr https://t.co/Ii1soSeAnT
November 7th 2017, 4:11pm
risk_averse_ @risk_averse_
RT @VCapital_invest: Positive Results for Multiple Sclerosis Patients $MNOV @davidbautz #biotech https://t.co/2B3p65ZUBK https://t.co/JJMxD…
November 7th 2017, 12:11pm
VCapital_invest @VCapital_invest
Positive Results for Multiple Sclerosis Patients $MNOV @davidbautz #biotech https://t.co/2B3p65ZUBK https://t.co/JJMxDAWNlg
November 7th 2017, 12:11pm
jimmiebjorling @jimmiebjorling
Positive Results for Multiple Sclerosis Patients $MNOV @davidbautz #biotech https://t.co/cx9vbLEngL https://t.co/s0OaVIn6wn
November 7th 2017, 12:11pm
lexooj @lexooj
Yet another day without the actual data from $MNOV . Really hope the company isn't going for one of those lousy Friday AH (fail) releases.
November 7th 2017, 7:11am
pharmascroll @pharmascroll
RT @BioStocks: $MNOV Announces Positive Top-Line Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS https://…
November 7th 2017, 2:11am
InsiderAlertsIA @InsiderAlertsIA
$MNOV: New Insider Filing on President and CEO YUICHI IWAKI: https://t.co/EHHpr8SOoK
November 6th 2017, 9:11am
ARatings @ARatings
The President & CEO of Medicinova is Exercising Options $MNOV https://t.co/KjEztDpIwO
November 6th 2017, 8:11am
confcalltran @confcalltran
MediciNova's President and CEO just picked up 21,067 shares https://t.co/Dzb9LNmLt7 $MNOV
November 6th 2017, 8:11am
filingBot @filingBot
@DaveSD80 there is a new form 4 filing for $MNOV https://t.co/nYR8awZsiR What do you think?
November 6th 2017, 8:11am
push4ms @push4ms
RT @vitalhongkong: NEW YORK (CBSNewYork) Asthma Drug May Slow Brain Damage In Multiple Sclerosis Patients $MNOV… https://t.co/SfzpjxV2KB
November 4th 2017, 9:11am
vitalhongkong @vitalhongkong
NEW YORK (CBSNewYork) Asthma Drug May Slow Brain Damage In Multiple Sclerosis Patients $MNOV… https://t.co/mZWOnqCERC
November 4th 2017, 9:11am
hpoooqh @hpoooqh
RT @ZacksSmallCap: $MNOV Positive Results in Phase 2b Study of MN-166 in Progressive MS @DavidBautz https://t.co/tR7VVW3MBe https://t.co/kw…
November 3rd 2017, 11:11am
ZacksSmallCap @ZacksSmallCap
$MNOV Positive Results in Phase 2b Study of MN-166 in Progressive MS @DavidBautz https://t.co/tR7VVW3MBe https://t.co/kw3eaZ7GAI
November 3rd 2017, 11:11am
CRWECrownEquity @CRWECrownEquity
$MNOV to present findings from ongoing clinical trial of MN-166 (ibudilast) in amyotrophic lateral sclerosis https://t.co/WtS0kyI35u
November 2nd 2017, 2:11am
stockboardinc @stockboardinc
$MNOV MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 28th Internati... - https://t.co/iXFhdQitsn
November 1st 2017, 7:11pm
GNWLive @GNWLive
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 28th International $MNOV https://t.co/SQvxlj7mRi
November 1st 2017, 7:11pm
stockmarketvid @stockmarketvid
(VIDEO LINK) How To Make Money From These Stocks: $MNOV $EFII https://t.co/v9lpfLcVku https://t.co/r4nvS9a9ZY
November 1st 2017, 5:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.